Equities

Longduoduo Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LDDD:PKC

Longduoduo Co Ltd

Actions
  • Price (USD)0.5933
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change-88.06%
  • Beta--
Data delayed at least 15 minutes, as of Nov 24 2025 15:23 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Longduoduo Co Ltd is a company principally engaged the provision of preventive care services. The Company provides solution for chronic disease problems through non-drug treatments and prevents cardiovascular and cerebrovascular diseases in advance. The Company offers health consultation and advice to customers and sells treatment services to customers, provided by Longduoduo to customers in local cooperative medical institutions. The Company's treatment projects mainly include ozone autologous blood transfusion (immunotherapy), Xingnao Tongluo therapy, double blood purification, platelet-rich plasma (PRP) injection therapy and others. The Company's products and services are mainly used for the prevention of myocardial infarction, cerebral infarction, hemiplegia, cardiovascular and cerebrovascular diseases.

  • Revenue in USD (TTM)4.15m
  • Net income in USD426.80k
  • Incorporated2021
  • Employees52.00
  • Location
    Longduoduo Co Ltd4-419, 2Nd Light Hospital, Ordos StreetHUHEHAOTE 010000ChinaCHN
  • Phone+86 4 725104980
  • Websitehttps://www.longduoduo.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Healthlynked Corp2.37m-3.83m9.82m20.00------4.13-1.36-1.360.8411-1.911.0520.871.51118,702.50-169.54-114.35---274.5751.2954.88-161.50-125.900.224-1.33-----47.43-5.63-69.66---23.71--
Selectis Health Inc42.17m-818.09k9.97m616.00----15.700.2364-0.2667-0.266713.75-1.841.26--16.5468,452.14-2.35-3.79-5.90-4.98-----1.87-4.83---0.9521.22--7.3641.6338.85---56.82--
Psychemedics Corp19.69m-1.86m10.14m101.00--1.98--0.5152-0.3199-0.31993.350.83961.91--6.36194,901.00-18.03-12.29-28.15-16.5936.0735.27-9.45-10.26---67.610.0535---10.92-12.1855.20---44.67--
Basel Medical Group Ltd8.95m-9.56m11.65m77.00--3.03--1.30-0.5087-0.50870.48060.20460.6827--5.71116,224.40-72.90---157.97-------106.79--1.192.220.4128--12.63---683.15------
Concord Medical Services Hldgs Ltd (ADR)52.84m-23.57m16.37m595.00------0.3098-5.39-5.3912.10-74.520.054815.235.4088,807.34-7.92-9.88-149.26-52.45-11.44-16.74-144.56-136.950.4122-17.310.679---28.5514.12-3.56---7.16--
Pacific Health Care Organization Inc6.67m1.45m16.90m29.0011.681.3211.462.530.1130.1130.52071.000.5248--6.32230,114.8011.396.4111.956.8781.6081.5721.7012.77----0.00--7.73-3.7215.06-5.91-31.19--
Longduoduo Co Ltd4.15m426.80k17.81m52.0041.7516.0930.954.290.01420.01420.13840.03692.34--29.6079,853.0824.80-105.7747.93--98.4289.7710.61-31.72----0.00---42.32---63.32------
Jun An Kang Group Inc4.47m-3.25m23.18m0.00------5.18-1,128.15-1,128.1524.83-3.451.25--8.10---91.08---654.07--49.14---72.75-----1.822.94--39.82---15.35------
Data as of Nov 24 2025. Currency figures normalised to Longduoduo Co Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.